287 related articles for article (PubMed ID: 21907219)
1. Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
Chu JM; Chen LW; Chan YS; Yung KK
Neuropharmacology; 2011 Dec; 61(8):1389-98. PubMed ID: 21907219
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin receptor 3 peptide exacerbates 6-hydroxydopamine-induced dopaminergic degeneration in rats through JNK pathway.
Chu JM; Chan YS; Chen LW; Yung KK
J Neurochem; 2012 Nov; 123(3):417-27. PubMed ID: 22762252
[TBL] [Abstract][Full Text] [Related]
3. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
Kopalli SR; Noh SJ; Koppula S; Suh YH
Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway.
Zhang XS; Ha S; Wang XL; Shi YL; Duan SS; Li ZA
Neuroscience; 2015 Sep; 303():489-502. PubMed ID: 26116522
[TBL] [Abstract][Full Text] [Related]
5. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
Decressac M; Pain S; Chabeauti PY; Frangeul L; Thiriet N; Herzog H; Vergote J; Chalon S; Jaber M; Gaillard A
Neurobiol Aging; 2012 Sep; 33(9):2125-37. PubMed ID: 21816512
[TBL] [Abstract][Full Text] [Related]
7. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
8. Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes.
Jiang Z; Yu PH
Neuroscience; 2005; 133(2):405-11. PubMed ID: 15878643
[TBL] [Abstract][Full Text] [Related]
9. Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells.
Manáková S; Singh A; Kääriäinen T; Taari H; Kulkarni SK; Männistö PT
Brain Res; 2005 Mar; 1038(1):83-91. PubMed ID: 15748876
[TBL] [Abstract][Full Text] [Related]
10. A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death.
Thornton E; Tran TT; Vink R
Neurosci Lett; 2010 Aug; 481(1):64-7. PubMed ID: 20599590
[TBL] [Abstract][Full Text] [Related]
11. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK
Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
13. G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway.
Huang HY; Lin SZ; Kuo JS; Chen WF; Wang MJ
Neurobiol Aging; 2007 Aug; 28(8):1258-69. PubMed ID: 16839644
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink DJ
Exp Neurol; 2001 Jun; 169(2):231-8. PubMed ID: 11358438
[TBL] [Abstract][Full Text] [Related]
18. Human Basic Fibroblast Growth Factor Inhibits Tau Phosphorylation via the PI3K/Akt-GSK3β Signaling Pathway in a 6-Hydroxydopamine-Induced Model of Parkinson's Disease.
Yang PH; Zhu JX; Huang YD; Zhang XY; Lei P; Bush AI; Xiang Q; Su ZJ; Zhang QH
Neurodegener Dis; 2016; 16(5-6):357-69. PubMed ID: 27228974
[TBL] [Abstract][Full Text] [Related]
19. IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells.
Gao QG; Xie JX; Wong MS; Chen WF
Eur J Pharmacol; 2012 Feb; 677(1-3):39-46. PubMed ID: 22227334
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
